Evidence map›Paper›PMID 30944677›Full record

ArticlePrzeglad gastroenterologiczny2019

Serum interleukin-35 and pentraxin-3 levels in patients with mild acute pancreatitis.

Evrim Kahramanoğlu Aksoy, Ferdane Pirinççi Sapmaz, Özlem Doğan, Zeynep Göktaş, Metin Uzman, Yaşar Nazlıgül

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Przeglad gastroenterologiczny, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Evrim Kahramanoğlu AksoyDepartment of Gastroenterology, Kecioren Training and Research Hospital, Ankara, Turkey.
Ferdane Pirinççi SapmazDepartment of Gastroenterology, Kecioren Training and Research Hospital, Ankara, Turkey.
Özlem DoğanDepartment of Biochemistry, Faculty of Medicine, Ankara University, Ankara, Turkey.
Zeynep GöktaşDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Hacettepe, Turkey.
Metin UzmanDepartment of Gastroenterology, Kecioren Training and Research Hospital, Ankara, Turkey.
Yaşar NazlıgülDepartment of Gastroenterology, Kecioren Training and Research Hospital, Ankara, Turkey.
Ankara University · TRHacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInterleukin-35 (IL-35) is a newly defined potent anti-inflammatory cytokine that is predominantly produced by regulatory T cells, and pentraxin-3 belongs to the acute-phase proteins.

aimTo measure the serum IL-35 and pentraxin-3 levels in the early phase of mild acute pancreatitis (AP). MATERIAL AND

methodsEighty-three patients with mild AP and 30 healthy controls were included in the study. The serum levels of IL-35 and pentraxin-3 were measured by enzyme-linked immunosorbent assay upon admission and at the 48

resultsThe mean value of serum IL-35 levels in patients with mild acute pancreatitis at admission was 5.91 ng/ml (4.21-7.90) and was significantly lower than those in healthy controls (25.53 ng/ml (12.79-54.73,

conclusionsInterleukin-35 can be used in diagnosis and follow-up in patients with mild AP.

Indexed as

interleukin-35mild acute pancreatitispentraxin-3

Identifiers

PMID30944677
PMCPMC6444112
OpenAlexW2921149273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.